WASHINGTON, Dec. 30 — The Food and Drug Administration announced Tuesday that the anthrax vaccine protected against the inhaled form of the bacteria, aiding government efforts to restart the Pentagon’s mandatory inoculation program, which was stalled by a federal injunction.
